Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 10-2025 | 07-2025 | 04-2025 | 01-2025 | 10-2024 | |
| Operating Expenses | 8,323 | 8,554 | 6,328 | 7,169 | 5,153 |
| Operating Income | -8,323 | -8,554 | -6,328 | -7,169 | -5,153 |
| Interest Expense | 0 | 0 | 0 | -67 | 0 |
| Other Income | 45 | 390 | 103 | 764 | -677 |
| Pre-tax Income | -8,278 | -8,164 | -6,225 | -6,338 | -5,829 |
| Net Income Continuous | -8,278 | -8,164 | -6,225 | -6,338 | -5,829 |
| Minority Interests | -81 | -73 | -98 | -46 | -27 |
| Net Income | $-8,198 | $-8,091 | $-6,127 | $-6,291 | $-5,802 |
| EPS Basic Total Ops | -4.35 | 10.18 | -16.40 | -23.30 | -32.67 |
| EPS Basic Continuous Ops | -4.39 | 10.12 | -16.66 | -23.47 | -32.75 |
| EPS Diluted Total Ops | -4.35 | 10.18 | -16.40 | -23.30 | -32.67 |
| EPS Diluted Continuous Ops | -4.39 | 10.12 | -16.66 | -23.47 | -32.75 |
| EPS Diluted Before Non-Recurring Items | -4.35 | N/A | -16.40 | -23.30 | -32.98 |
| EBITDA(a) | $-8,296 | $-8,528 | $-6,302 | $-7,143 | $-5,126 |